Article

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and Outcomes

2021-09-16

Abstract excerpt

<h4>Background: </h4> To investigate the clinical characteristics, treatment and outcomes of myasthenia gravis with antibodies to the muscle-specific tyrosine kinase (MuSK-MG). <h4>Methods: </h4>: We retrospectively reviewed 21 patients with confirmed MuSK-MG between January 2012 to January 2020 in our center. Detailed clinical data and long-term follow up information were summarized. <h4>Results: </h4>: Females (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e2dc5f8c-fc21-51ef-9e31-e7735be757b8
DOI: 10.21203/rs.3.rs-853800/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesDOI 10.21203/rs.3.rs-853800/v1Read

Clinical characteristics and outcome of treatment-refractory myasthenia gravis -a retrospective studySemantic proximity Read

Clinical and Demographic Features of Distal Extremity Weakness in Myasthenia Gravis - A Scoping ReviewSemantic proximity Read

HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.Semantic proximity Read

Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.Semantic proximity Read

Complicating autoimmune diseases in myasthenia gravis: a review.Semantic proximity Read

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read

A unique subphenotype of myasthenia gravis.Semantic proximity Read

Real-World Case Series of Efgartigimod for Generalized Myasthenia Gravis：Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom ControlSemantic proximity Read

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read

A Retrospective Longitudinal Cohort Study of The Clinical Burden in Myasthenia GravisSemantic proximity Read

Dilemma on Animal Models for Ocular Myasthenia Gravis: Can Lipoprotein Receptor-related Protein 4 Experimental Autoimmune Myasthenia Gravis Fix This Problem?Semantic proximity Read